DOC-001 / CoA
Semaglutide Certificate of Analysis
These values apply only to the recorded sample and CoA. They are not a future-batch result or a product-wide guarantee.
Acylated peptide API
Semaglutide API Raw Material for Qualified B2B Programs
LUMIRABIO supports Semaglutide API projects with synthesis, purification, analytical review and batch documentation. Review the reference identity and published document examples, then share your required material form, quantity, target market and documents for a project-specific supply assessment.
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
- Formula
- C187H291N45O59
- CAS
- 910463-68-2
- Average MW
- 4113.58 g/mol
Product Introduction
Semaglutide is a long-acting, acylated GLP-1 analogue with 94% sequence homology to human GLP-1. LUMIRABIO provides an integrated peptide API raw material package covering molecular identity, modification state, supplied form, specification, purity and related-peptide profile, and batch documentation.
Reference identity
Product Parameters
Public identity fields organize the first review. Formal specifications and batch records govern the proposed supplied material.
| Parameter | Reference / specification | Source and scope |
|---|---|---|
| Product name | Semaglutide | Supplied form confirmed per project |
| CAS | 910463-68-2 | Named reference identity; formal documents govern the supplied material |
| Formula | C187H291N45O59 | NIH PubChem reference identity Not a batch measurement; counter-ion and supplied form require confirmation |
| Average MW | 4113.58 g/mol | |
| Peptide class | 31 amino-acid residues | Reference sequence identity |
| Portfolio specification | ≥99% by HPLC | Batch-specific result and applicable method per CoA |
| Single impurity / storage | Confirm for the specification and batch | No universal limit or storage-temperature guarantee |
Sequence / structure H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Material definition
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
Semaglutide sourcing review
Prepare a Clear Semaglutide API Inquiry
Align the material, evidence and delivery requirements before comparing a quotation or planning a shipment.
- 01
What material should be quoted?
Confirm the supplied form and counter-ion, target specification and quantity. The parent-peptide CAS number alone does not define the material required for your project.
Review manufacturing capabilities - 02
Which documents should you review?
Use the published CoA and HPLC examples as a starting point. Request the specification, applicable methods and records for the proposed batch; displayed sample results apply to the recorded sample.
Read the Semaglutide document-review guide - 03
What is needed for a supply discussion?
Share your institutional use, target market, destination, timing and required documents. Available capacity, packaging and delivery arrangements are confirmed for the specific project.
Discuss your Semaglutide requirements
Semaglutide Batch-Supporting Documents
Each entry preserves the sample, method, date, reported result, issuer information, and product mapping of its source record.
DOC-002 / HPLC
Semaglutide HPLC Chromatogram
Analysed at 210 nm with manual integration. Peak area is not a content result and is not extrapolated to future batches.
Batch record review
Original records connect the issuer, sample identity, batch, method, date, result, disclosure status, and product mapping in one traceable review.